New drug cocktail aims to rescue HIV patients when other treatments fail
NCT ID NCT00196625
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of three HIV drugs (amprenavir, lopinavir, and ritonavir) in patients whose current treatments are no longer working. The goal is to see if this new mix can lower the amount of HIV in the blood over 26 weeks. Participants are HIV-positive adults who have tried multiple previous therapies without success. The study compares two different doses of ritonavir to find the safest and most effective option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
amprenavir, lopinavir, and ritonavir
What this could lead to
If successful, this combination could offer a new treatment option for people with HIV who have not responded to other therapies.
What could go wrong
This is a Phase 2 trial with only 100 participants, so results may not apply to everyone. The drugs can cause side effects and may not work for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine
Paris, France